10x Genomics, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-80.89
Forward P/E Ratio
136.45
PEG Ratio
1.26
-90.65
Price-to-Sales (TTM)
5.42
4.38
6.24
Market Cap
3.59B
2.78B
Is it profitable?
Net Profit Margin (TTM)
-3.55%
Gross Profit Margin
70.39%
Diluted EPS (TTM)
-0.17
-2.98%
638.78M
Is it growing?
-2.60%
-2.61%
Is it risky?
2.05
10.00
5.90
81.39M
Who owns it?
110.38%
1.67%
25.91%
128.99M
115.09M
Does it pay?
0.00%
0.00%
--
--
How much cash?
539.85M
127.82M
124.55M
4.25
- Price
- 28.31
- Percent Change
- +0.32 (1.13%)
- Previous Close
- 27.99
- Open
- 27.86
- Low
- 27.33
- High
- 28.85
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$28.31
From 52W Low
+221.28%
From 52W High
-1.89%
Today
+1.13%
1Y Change
+199.52%
6M
$18.08
3M
$23.14
1M
$22.05
Today
$28.31
From 52W Low
+221.28%
From 52W High
-1.89%
Today
+1.13%
1Y Change
+199.52%
6M
$18.08
3M
$23.14
1M
$22.05
Today
$28.31
Expensive
within its 1-year price range
$28.31
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+28.4%
3M
+22.3%
6M
+56.6%
1Y
+199.5%
Rate of Change (ROC)
Accelerating
Price is rising 2.5x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- 2012
- CEO
- Serge Saxonov
- Employees
- 1,306
- Fiscal Year End
- Dec 31, 2024
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com
Indicators
Operating Cash Flow
127.82M
Net Income
-22.66M
Warning Sign
-5.64
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |
Indicators
Operating Cash Flow
127.82M
Net Income
-22.66M
Warning Sign
-5.64
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-80.89
Forward P/E Ratio
136.45
PEG Ratio
1.26
-90.65
Price-to-Sales (TTM)
5.42
4.38
6.24
Market Cap
3.59B
2.78B
Is it profitable?
Net Profit Margin (TTM)
-3.55%
Gross Profit Margin
70.39%
Diluted EPS (TTM)
-0.17
-2.98%
638.78M
Is it growing?
-2.60%
-2.61%
Is it risky?
2.05
10.00
5.90
81.39M
Who owns it?
110.38%
1.67%
25.91%
128.99M
115.09M
Does it pay?
0.00%
0.00%
--
--
How much cash?
539.85M
127.82M
124.55M
4.25
- Price
- 28.31
- Percent Change
- +0.32 (1.13%)
- Previous Close
- 27.99
- Open
- 27.86
- Low
- 27.33
- High
- 28.85
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$28.31
From 52W Low
+221.28%
From 52W High
-1.89%
Today
+1.13%
1Y Change
+199.52%
6M
$18.08
3M
$23.14
1M
$22.05
Today
$28.31
From 52W Low
+221.28%
From 52W High
-1.89%
Today
+1.13%
1Y Change
+199.52%
6M
$18.08
3M
$23.14
1M
$22.05
Today
$28.31
Expensive
within its 1-year price range
$28.31
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+28.4%
3M
+22.3%
6M
+56.6%
1Y
+199.5%
Rate of Change (ROC)
Accelerating
Price is rising 2.5x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- 2012
- CEO
- Serge Saxonov
- Employees
- 1,306
- Fiscal Year End
- Dec 31, 2024
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |